These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29891072)

  • 1. Drug treatment.
    Perlman S; Boltshauser E
    Handb Clin Neurol; 2018; 155():371-377. PubMed ID: 29891072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
    Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M
    Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus paper: management of degenerative cerebellar disorders.
    Ilg W; Bastian AJ; Boesch S; Burciu RG; Celnik P; Claaßen J; Feil K; Kalla R; Miyai I; Nachbauer W; Schöls L; Strupp M; Synofzik M; Teufel J; Timmann D
    Cerebellum; 2014 Apr; 13(2):248-68. PubMed ID: 24222635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of synthetic pharmacotherapy for recessive cerebellar ataxias.
    Beaudin M; Dupre N; Manto M
    Expert Rev Neurother; 2024 Sep; 24(9):897-912. PubMed ID: 38980086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatments of cerebellar ataxia.
    Ogawa M
    Cerebellum; 2004; 3(2):107-11. PubMed ID: 15233578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open trial of amantadine and buspirone for cerebellar ataxia: a disappointment.
    Hassin-Baer S; Korczyn AD; Giladi N
    J Neural Transm (Vienna); 2000; 107(10):1187-9. PubMed ID: 11129108
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias.
    Barca E; Emmanuele V; DiMauro S; Toscano A; Quinzii CM
    Curr Neuropharmacol; 2019; 17(1):21-32. PubMed ID: 29119930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebellar Ataxia.
    Perlman SL
    Curr Treat Options Neurol; 2000 May; 2(3):215-224. PubMed ID: 11096749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.
    Hadjivassiliou M
    CNS Neurol Disord Drug Targets; 2019; 18(6):423-431. PubMed ID: 29268693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M
    Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cerebellar ataxia.
    Jones TM; Shaw JD; Sullivan K; Zesiewicz TA
    Neurodegener Dis Manag; 2014; 4(5):379-92. PubMed ID: 25405651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of buspirone, a serotonergic 5-HT-1A agonist in cerebellar ataxia: a pilot study. Preliminary communication].
    Trouillas P; Xie J; Getenet JC; Adeleine P; Nighoghossian N; Honnorat J; Riche G; Derex L
    Rev Neurol (Paris); 1995 Dec; 151(12):708-13. PubMed ID: 8787101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic developments in chronic ataxias].
    Buompadre MC
    Medicina (B Aires); 2013; 73 Suppl 1():49-54. PubMed ID: 24072051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowly progressive cerebellar ataxia and cervical dystonia: clinical presentation of a new form of spinocerebellar ataxia?
    Kuoppamäki M; Giunti P; Quinn N; Wood NW; Bhatia KP
    Mov Disord; 2003 Feb; 18(2):200-6. PubMed ID: 12539216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introducing treatment strategy for cerebellar ataxia in mutant med mice: combination of acetazolamide and 4-aminopyridine.
    Abbasi S; Abbasi A; Sarbaz Y
    Comput Methods Programs Biomed; 2014 Feb; 113(2):697-704. PubMed ID: 24326337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurological update: therapies for cerebellar ataxias in 2020.
    Gandini J; Manto M; Bremova-Ertl T; Feil K; Strupp M
    J Neurol; 2020 Apr; 267(4):1211-1220. PubMed ID: 32002650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar and afferent ataxias.
    Pandolfo M; Manto M
    Continuum (Minneap Minn); 2013 Oct; 19(5 Movement Disorders):1312-43. PubMed ID: 24092292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cerebellar ataxia with 5-HT1A agonist.
    Takei A; Hamada T; Yabe I; Sasaki H
    Cerebellum; 2005; 4(3):211-5. PubMed ID: 16147954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cerebellar ataxia with buspirone: a double-blind study.
    Trouillas P; Xie J; Adeleine P
    Lancet; 1996 Sep; 348(9029):759. PubMed ID: 8806320
    [No Abstract]   [Full Text] [Related]  

  • 20. [Buspirone chlorhydrate in the treatment of cerebellar ataxia].
    Andrade-Filho AS; Passos-Almeida J; Andrade-Souza VM; Sena-Pereira LR
    Rev Neurol; 2002 Aug 16-31; 35(4):301-5. PubMed ID: 12235556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.